Increased resistin concentration predicts all-cause mortality. by Karri Parkkila (10219221)

Table 1_Serum tyrosine increases all-cause mortality in an older population.docx by Yuhong Dai (16990752)

“…</p>Conclusions<p>Elevated serum tyrosine levels are independently associated with an increased risk of all-cause mortality, and may serve as a valuable biomarker for mortality risk prediction in Chinese older adults.…”

MS decreases the larger amplitude distribution in adult rats. by Jesús David Ayala-Rodríguez (17364296)

RCS for all-cause mortality. by Sheng Chen (21971)

RCS for all-cause mortality. by Sheng Chen (21971)

“…Kaplan-Meier survival analysis, Cox proportional hazard models, and restricted cubic spline regression were applied to evaluate the association between EASIX and 30- and 60-day all-cause mortality. Subgroup analyses were also performed to assess interactions with key patient characteristics.…”

Table1_The role of glucocorticoids in increasing cardiovascular risk.docx by Hai-Wei Deng (16493715)

“…</p>Conclusions<p>Administration of GCs is possibly related with increased risk for MACE, CHD, and HF but not increased all-cause death or stroke. …”

Image1_The role of glucocorticoids in increasing cardiovascular risk.tiff by Hai-Wei Deng (16493715)

“…</p>Conclusions<p>Administration of GCs is possibly related with increased risk for MACE, CHD, and HF but not increased all-cause death or stroke. …”

Image2_The role of glucocorticoids in increasing cardiovascular risk.tiff by Hai-Wei Deng (16493715)

“…</p>Conclusions<p>Administration of GCs is possibly related with increased risk for MACE, CHD, and HF but not increased all-cause death or stroke. …”

Table3_The role of glucocorticoids in increasing cardiovascular risk.doc by Hai-Wei Deng (16493715)

“…</p>Conclusions<p>Administration of GCs is possibly related with increased risk for MACE, CHD, and HF but not increased all-cause death or stroke. …”

Table2_The role of glucocorticoids in increasing cardiovascular risk.doc by Hai-Wei Deng (16493715)

“…</p>Conclusions<p>Administration of GCs is possibly related with increased risk for MACE, CHD, and HF but not increased all-cause death or stroke. …”

Supplementary Material for: Clinical Implications of Decreased Computed Tomography Value after Ramucirumab in Advanced Gastric Cancer by Izawa N. (6834062)

“…<b><i>Conclusions:</i></b> Patients with aGC treated with ramucirumab experienced a significant decrease of CT value of tumors and had an association between the rate of CT value change and PFS. …”

Data Sheet 1_Decrease in low-density lipoprotein cholesterol is associated with an increased risk of mortality in patients with diabetes mellitus.docx by Yun Gi Kim (9450226)

Boxplot comparing Ct values for HD in flies and clothes. by Philippe Ndzomo (17706039)

Stratified analysis of osteoporosis and all-cause mortality (weighted). by Xiaoqin Qu (20923646)

Osteoporosis and all-cause mortality survival curve (weighted). by Xiaoqin Qu (20923646)

DataSheet_1_Higher plasma aldosterone is associated with increased risk of cardiovascular events in hypertensive patients with suspected OSA: UROSAH data.docx by Lin Gan (114079)

“…</p>Conclusion<p>Higher PAC was associated with increased risk of CVD and all-cause mortality in hypertensives with suspected OSA, even in the absence of primary aldosteronism (PA). …”

Adjusted all-cause mortality according to AS stage. by Jordan B. Strom (4237204)

Association of INR and all-cause mortality. by Graciela E. Delgado (3687640)

“…<p>Cox proportional hazard regression has been used to calculate the risk of all-cause mortality per 1-SD increase in the INR. …”

Cumulative incidence plot for all-cause hospitalizations. by Tetyana Kendzerska (519437)

Predictors of all-cause mortality. by Edwin A. Homan (1335243)